ArticleBMC pharmacology & toxicology2026
Integrated network toxicology, molecular docking, and molecular dynamics simulation reveals mechanisms of benzo[a]pyrene-induced pan-cancer.
Article in BMC pharmacology & toxicology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
backgroundBenzo[a]pyrene (B[a]P), a ubiquitous environmental pollutant, is prevalent in emissions, food products, and tobacco. Although B[a]P’s carcinogenicity is well-established, the common molecular mechanisms underlying its pan-cancer carcinogenesis remain incompletely understood. This study systematically investigated B[a]P’s shared pathogenic mechanisms in 10 common solid tumors: bladder, breast, cervical, colorectal, esophageal, gastric, liver, lung, prostatic, and thyroid cancer.
methodsComputational tools assessed B[a]P toxicity and identified targets. Disease targets for each cancer were retrieved from databases. Intersection analysis found candidate targets. Core targets were identified via protein-protein interaction network. GO/KEGG analyses revealed biological roles and pathways. The binding performance of B[a]P to the core targets was analyzed using molecular docking and molecular dynamics simulations.
resultsCancer-specific potential toxicity targets were identified (range: n = 40–59). Enrichment analysis revealed conserved carcinogenic pathways across cancer types, including cellular response to xenobiotic stimuli, chemical carcinogen-induced receptor activation and DNA adduct formation, cytochrome P450-mediated xenobiotic metabolism, endocrine resistance, steroid hydroxylase activity, and calcium signaling pathways. Common core targets included ESR1, EGFR, MAPK3, MMP9, and PTGS2. Molecular docking and dynamics simulations confirmed strong B[a]P binding to these targets.
conclusionThis study elucidated fundamental molecular features of B[a]P-induced pan-carcinogenesis, providing a theoretical framework for developing universal prevention and therapeutic strategies.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.